Pricing Reports

NICE INSIGHT REPORT

Mammalian Cell Culture, Biologics: 2024 Market Insight, CDMO Pricing and Competitor Benchmarking

Published June 2024
  • 2024 pricing data for benchmarking and informed decision-making
  • Pricing trends since 2019 and 2024 regional pricing breakdown (NA/EU/APAC)
  • 74 profiles of biologics CDMOs specializing in mammalian cell culture
  • Pricing for 82 distinct line items
  • Clinical trial analysis of bispecific modalities, including top therapeutic targets
  • Analysis of trends and challenges in bispecific cell line development and manufacturing
Learn More
Mammalian Cell Culture, Biologics

206 pages of primary market research to support your sales team and inform your business strategy. Feedback, insights, trends, and predictions from some of the mammalian-based biologics sector’s most influential opinion leaders and decision makers.

Key market insights for innovators, CDMOs and investors in the biologics industry.

Make better decisions with our pricing report

Discover the mammalian cell culture contract development and manufacturing market with our comprehensive study on top CDMOs and insights into manufacturing trends. Benchmark your business with our in-depth pricing studies, which use years of primary data, to see how to best position your business. Dive into the focus on production of antibodies and antibody-based therapeutics.

 

Essential mammalian cell culture analysis

Understand the unique complexities of developing mammalian-based biologics and the trends and technologies shaping the market from exclusive insights from PhD scientists, NMEs and respected voices in the biopharma industry.